Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-5-9
pubmed:abstractText
Evaluation of the effectiveness and safety of the low molecular weight heparin (LMWH) tinzaparin versus unfractionated heparin (UFH) followed by acenocoumarol in proximal deep venous thrombosis (DVT).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1078-5884
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
638-50
pubmed:dateRevised
2007-10-4
pubmed:meshHeading
pubmed-meshheading:15878544-Acenocoumarol, pubmed-meshheading:15878544-Administration, Oral, pubmed-meshheading:15878544-Adult, pubmed-meshheading:15878544-Aged, pubmed-meshheading:15878544-Aged, 80 and over, pubmed-meshheading:15878544-Drug Therapy, Combination, pubmed-meshheading:15878544-Female, pubmed-meshheading:15878544-Follow-Up Studies, pubmed-meshheading:15878544-Heparin, pubmed-meshheading:15878544-Heparin, Low-Molecular-Weight, pubmed-meshheading:15878544-Humans, pubmed-meshheading:15878544-Infusions, Intravenous, pubmed-meshheading:15878544-Injections, Subcutaneous, pubmed-meshheading:15878544-Long-Term Care, pubmed-meshheading:15878544-Male, pubmed-meshheading:15878544-Middle Aged, pubmed-meshheading:15878544-Partial Thromboplastin Time, pubmed-meshheading:15878544-Pulmonary Embolism, pubmed-meshheading:15878544-Recurrence, pubmed-meshheading:15878544-Ultrasonography, Doppler, Duplex, pubmed-meshheading:15878544-Vascular Patency, pubmed-meshheading:15878544-Venous Thrombosis
pubmed:year
2005
pubmed:articleTitle
Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial.
pubmed:affiliation
Department of Vascular Surgery, Athens University Medical School, Athens, Greece.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't